Counselors in Leakesville, MS Accepting Medicare
6 Counselors found. Showing 1 - 6
 Kaneesha Roby, PCIDDT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 710 Oak St, Leakesville, MS 39451 Phone: 601-394-2887 |
Diona Dickerson, CCSS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1501 Lackey St, Leakesville, MS 39451 Phone: 601-394-5047 |
Amanda Johnson, PCMHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1501 Lackey St, Leakesville, MS 39451 Phone: 601-394-5047 Fax: 601-394-6542 |
Jennifer Fisher, PCMHT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1501 Lackey St, Leakesville, MS 39451 Phone: 601-394-5047 |
Olivia Roberts, PCCSSS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1501 Lackey St, Leakesville, MS 39451 Phone: 601-394-5047 Fax: 601-394-6542 |
Amber Davis, PCCSS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1501 Lackey St, Leakesville, MS 39451 Phone: 601-394-5047 |
News Archive
EHSI negotiates potential option agreement with Regenetech for Rotary Cell Culture System
Emerging Healthcare Solutions, Inc. is negotiating a potential option agreement with biotech firm Regenetech, Inc.
Scientists analyze genetic characteristics of cancers using multiple genomic technology platforms
New research partly led by UC San Francisco-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated, and that this information, in turn, could lead to more appropriate treatments.
Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems
​Joseph C. Glorioso, III, PhD (University of Pittsburgh School of Medicine, PA) devoted much of his research career to developing herpes viruses as efficient vectors for delivering therapeutic genes into cells.
› Verified 8 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists